Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This could be the buy of 2018!!!!
That jumbled pile of mess is Fraud. I'm sure your employers would love to have a libel suit on their hands.
Been gone all day. Come home to see this... Its like watching a baby take its first steps! There is still tons of room left on this run!
Oh wow....I'm jealous of the .0008 I'm averaged at .0023 and still very very happy
I agree!!! You should short it now...I'd say bet the ho
use!
NPHC News
Nutra Pharma Announces Nyloxin® Distribution Agreement for Australia and New Zealand
February 1, 2018
February 1, 2018 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis (MS) and HIV and that also markets the over-the-counter (OTC) pain drugs; Nyloxin® and Pet Pain-Away™, announced today that they have signed a definitive Distribution Agreement with the Australian company, Pharmachal PTY LTD to market and distribute Nyloxin® in Australia and New Zealand.
“We recently announced our domestic efforts to increase sales and distribution of Nyloxin," stated Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. "This included the new website, web promotions and our application to be added to the Federal Supply Schedule for sales to US governmental agencies,” he continued. “I'm excited to announce that we have also been working to promote our products internationally. We have been moving forward with our efforts in Canada and India – and we are now announcing our agreement with Pharmachal to be our exclusive distributor of Nyloxin in Australia and New Zealand. Once they receive regulatory approval through the TGA, they will be able to warehouse, market and distribute Nyloxin throughout their territories. We believe this will allow for broad distribution and marketing in that region by the end of this year,” he concluded.
According to Euromonitor, the OTC analgesics drug category in Australia was worth US$627 million in 2017. The new ban on OTC sales of codeine in Australia is expected to be the biggest factor impacting growth in analgesics. In December 2016, Australia’s drug regulator, the Therapeutic Goods Administration (TGA), shifted painkillers containing codeine to be listed as schedule one drugs that can only be sold with a prescription due to concerns about the addictive nature of codeine. While the total analgesic market is expected to shrink over the next ten years, the OTC market is expected to grow, especially with the launch of Amazon in Australia this year. As a result of the codeine ban, consumers are increasingly expected to turn to alternative combination analgesics that require no prescription, to avoid visiting a doctor.
“We are extremely pleased to be working with Nutra Pharma Corp.," commented Charles Fridlender, CEO of Pharmachal PTY LTD. "We believe that Nyloxin could be a disruptive product in the Australian marketplace. This is especially true with the recent crackdown on opiates in Australia and throughout the world. This non-opiate, non-narcotic product could have a ready audience in our markets," he continued. "We are already working with our regulatory authorities to get Nyloxin approved for re-sale in the Australian market as soon as possible. We expect to make the products available this calendar year,” he concluded.
Nyloxin® is an over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Nyloxin® is currently available as an oral spray for treating back pain, neck aches, headaches, joint pain, migraines, and neuralgia, and as a topical gel for treating joint pain, neck pain, arthritis pain, and pain from repetitive stress. In addition to its everyday strength formulation, Nyloxin® is also offered in an extra strength formula for more advanced, Stage 3, chronic pain.
About Pharmachal PTY LTD.
Pharmachal is a pharmaceutical, medical device and veterinary company based in Melbourne, Australia. The company develops, manufactures and distributes its products through medical specialists and will soon distribute direct to customers in Australia and internationally. Pharmachal has developed a patented mini emulsion delivery system in a spray for oral and dermal application. Only the best ingredients and materials are chosen for Phamachal products, based on rigorous research and exacting attention to detail. For additional information about Pharmachal, visit:
https://www.pharmachal.com
NPHC News
Nutra Pharma Announces Nyloxin® Distribution Agreement for Australia and New Zealand
February 1, 2018
February 1, 2018 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis (MS) and HIV and that also markets the over-the-counter (OTC) pain drugs; Nyloxin® and Pet Pain-Away™, announced today that they have signed a definitive Distribution Agreement with the Australian company, Pharmachal PTY LTD to market and distribute Nyloxin® in Australia and New Zealand.
“We recently announced our domestic efforts to increase sales and distribution of Nyloxin," stated Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. "This included the new website, web promotions and our application to be added to the Federal Supply Schedule for sales to US governmental agencies,” he continued. “I'm excited to announce that we have also been working to promote our products internationally. We have been moving forward with our efforts in Canada and India – and we are now announcing our agreement with Pharmachal to be our exclusive distributor of Nyloxin in Australia and New Zealand. Once they receive regulatory approval through the TGA, they will be able to warehouse, market and distribute Nyloxin throughout their territories. We believe this will allow for broad distribution and marketing in that region by the end of this year,” he concluded.
According to Euromonitor, the OTC analgesics drug category in Australia was worth US$627 million in 2017. The new ban on OTC sales of codeine in Australia is expected to be the biggest factor impacting growth in analgesics. In December 2016, Australia’s drug regulator, the Therapeutic Goods Administration (TGA), shifted painkillers containing codeine to be listed as schedule one drugs that can only be sold with a prescription due to concerns about the addictive nature of codeine. While the total analgesic market is expected to shrink over the next ten years, the OTC market is expected to grow, especially with the launch of Amazon in Australia this year. As a result of the codeine ban, consumers are increasingly expected to turn to alternative combination analgesics that require no prescription, to avoid visiting a doctor.
“We are extremely pleased to be working with Nutra Pharma Corp.," commented Charles Fridlender, CEO of Pharmachal PTY LTD. "We believe that Nyloxin could be a disruptive product in the Australian marketplace. This is especially true with the recent crackdown on opiates in Australia and throughout the world. This non-opiate, non-narcotic product could have a ready audience in our markets," he continued. "We are already working with our regulatory authorities to get Nyloxin approved for re-sale in the Australian market as soon as possible. We expect to make the products available this calendar year,” he concluded.
Nyloxin® is an over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Nyloxin® is currently available as an oral spray for treating back pain, neck aches, headaches, joint pain, migraines, and neuralgia, and as a topical gel for treating joint pain, neck pain, arthritis pain, and pain from repetitive stress. In addition to its everyday strength formulation, Nyloxin® is also offered in an extra strength formula for more advanced, Stage 3, chronic pain.
About Pharmachal PTY LTD.
Pharmachal is a pharmaceutical, medical device and veterinary company based in Melbourne, Australia. The company develops, manufactures and distributes its products through medical specialists and will soon distribute direct to customers in Australia and internationally. Pharmachal has developed a patented mini emulsion delivery system in a spray for oral and dermal application. Only the best ingredients and materials are chosen for Phamachal products, based on rigorous research and exacting attention to detail. For additional information about Pharmachal, visit:
https://www.pharmachal.com
RNVA News - Beat down to a 52 week low yesterday.
Rennova Health Announces Definitive Agreement to Acquire Jamestown, Tennessee Hospital From Community Health Systems
MARKET WIRE 3:15 PM ET 01/31/2018
Symbol Last Price Change
RNVA 0.0165down -0.0035 (-17.5%)
CYH 5.65down -0.12 (-2.08%)
QUOTES AS OF 03:56:24 PM ET 01/31/2018
WEST PALM BEACH, FL -- (Marketwired) -- 01/31/18 -- Rennova Health, Inc.(RNVA), ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, that opened its first rural hospital in Oneida, Tenn. in August 2017, announced today that it has entered into a definitive asset purchase agreement to acquire an acute care hospital in Jamestown, Tenn. The hospital known as Tennova Healthcare - Jamestown, and its associated assets are being acquired from Community Health Systems, Inc.(CYH). The transaction is expected to close in the second quarter of 2018, subject to customary regulatory approvals and closing conditions.
Tennova Healthcare - Jamestown is a fully operational 85-bed facility including a 24/7 emergency department, radiology department, surgical center, and a wound care & hyperbaric center. The purchase includes a 90,000 sq. ft. hospital building on approximately 8 acres.
"This acquisition further demonstrates our commitment to expanding Rennova's rural hospital model to provide necessary services to patients while securing more predictable recurring revenues," said Seamus Lagan, CEO of Rennova. "This hospital is approximately 38 miles (less than a one-hour drive) from our current hospital in Oneida and will benefit by receiving patients from Oneida that require operations and treatment not provided there. The synergy of management and services in a close geographic location creates numerous efficiencies for Rennova and will allow us to support a greater number of health care providers and residents in the local area."
About Rennova Health, Inc.(RNVA)
Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company's most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Contacts:
Rennova Health(RNVA)
Sebastien Sainsbury, 561-666-9818
ssainsbury@rennovahealth.com
Investors
LHA
Kim Golodetz, 212-838-3777
Kgolodetz@lhai.com
or
Bruce Voss, 310-691-7100
Bvoss@lhai.com
Source: Rennova Health, Inc.(RNVA)
RNVA News - Beat down to a 52 week low yesterday.
Rennova Health Announces Definitive Agreement to Acquire Jamestown, Tennessee Hospital From Community Health Systems
MARKET WIRE 3:15 PM ET 01/31/2018
Symbol Last Price Change
RNVA 0.0165down -0.0035 (-17.5%)
CYH 5.65down -0.12 (-2.08%)
QUOTES AS OF 03:56:24 PM ET 01/31/2018
WEST PALM BEACH, FL -- (Marketwired) -- 01/31/18 -- Rennova Health, Inc.(RNVA), ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, that opened its first rural hospital in Oneida, Tenn. in August 2017, announced today that it has entered into a definitive asset purchase agreement to acquire an acute care hospital in Jamestown, Tenn. The hospital known as Tennova Healthcare - Jamestown, and its associated assets are being acquired from Community Health Systems, Inc.(CYH). The transaction is expected to close in the second quarter of 2018, subject to customary regulatory approvals and closing conditions.
Tennova Healthcare - Jamestown is a fully operational 85-bed facility including a 24/7 emergency department, radiology department, surgical center, and a wound care & hyperbaric center. The purchase includes a 90,000 sq. ft. hospital building on approximately 8 acres.
"This acquisition further demonstrates our commitment to expanding Rennova's rural hospital model to provide necessary services to patients while securing more predictable recurring revenues," said Seamus Lagan, CEO of Rennova. "This hospital is approximately 38 miles (less than a one-hour drive) from our current hospital in Oneida and will benefit by receiving patients from Oneida that require operations and treatment not provided there. The synergy of management and services in a close geographic location creates numerous efficiencies for Rennova and will allow us to support a greater number of health care providers and residents in the local area."
About Rennova Health, Inc.(RNVA)
Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company's most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Contacts:
Rennova Health(RNVA)
Sebastien Sainsbury, 561-666-9818
ssainsbury@rennovahealth.com
Investors
LHA
Kim Golodetz, 212-838-3777
Kgolodetz@lhai.com
or
Bruce Voss, 310-691-7100
Bvoss@lhai.com
Source: Rennova Health, Inc.(RNVA)
RNVA News - Beat down to a 52 week low yesterday.
Rennova Health Announces Definitive Agreement to Acquire Jamestown, Tennessee Hospital From Community Health Systems
MARKET WIRE 3:15 PM ET 01/31/2018
Symbol Last Price Change
RNVA 0.0165down -0.0035 (-17.5%)
CYH 5.65down -0.12 (-2.08%)
QUOTES AS OF 03:56:24 PM ET 01/31/2018
WEST PALM BEACH, FL -- (Marketwired) -- 01/31/18 -- Rennova Health, Inc.(RNVA), ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, that opened its first rural hospital in Oneida, Tenn. in August 2017, announced today that it has entered into a definitive asset purchase agreement to acquire an acute care hospital in Jamestown, Tenn. The hospital known as Tennova Healthcare - Jamestown, and its associated assets are being acquired from Community Health Systems, Inc.(CYH). The transaction is expected to close in the second quarter of 2018, subject to customary regulatory approvals and closing conditions.
Tennova Healthcare - Jamestown is a fully operational 85-bed facility including a 24/7 emergency department, radiology department, surgical center, and a wound care & hyperbaric center. The purchase includes a 90,000 sq. ft. hospital building on approximately 8 acres.
"This acquisition further demonstrates our commitment to expanding Rennova's rural hospital model to provide necessary services to patients while securing more predictable recurring revenues," said Seamus Lagan, CEO of Rennova. "This hospital is approximately 38 miles (less than a one-hour drive) from our current hospital in Oneida and will benefit by receiving patients from Oneida that require operations and treatment not provided there. The synergy of management and services in a close geographic location creates numerous efficiencies for Rennova and will allow us to support a greater number of health care providers and residents in the local area."
About Rennova Health, Inc.(RNVA)
Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company's most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Contacts:
Rennova Health(RNVA)
Sebastien Sainsbury, 561-666-9818
ssainsbury@rennovahealth.com
Investors
LHA
Kim Golodetz, 212-838-3777
Kgolodetz@lhai.com
or
Bruce Voss, 310-691-7100
Bvoss@lhai.com
Source: Rennova Health, Inc.(RNVA)
Patiently awaiting the appointment of the board and the symbol change. My vote is for (BUDS).
Lets hit .0149 first! I like the enthusiasm though!
Lets start at a nickel. Then we will worry about .25 and .50
It is strange. 911 trade then a 1 million share dump at market. Seems a bit odd. But cost them about $500 when it closed green!
NPHC is like a little champion! It churned and churned all day to finish green! So proud... lol
After hours News
Rennova Health Announces Definitive Agreement to Acquire Jamestown, Tennessee Hospital From Community Health Systems
MARKET WIRE 3:15 PM ET 01/31/2018
Symbol Last Price Change
RNVA 0.0165down -0.0035 (-17.5%)
CYH 5.65down -0.12 (-2.08%)
QUOTES AS OF 03:56:24 PM ET 01/31/2018
WEST PALM BEACH, FL -- (Marketwired) -- 01/31/18 -- Rennova Health, Inc.(RNVA), ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, that opened its first rural hospital in Oneida, Tenn. in August 2017, announced today that it has entered into a definitive asset purchase agreement to acquire an acute care hospital in Jamestown, Tenn. The hospital known as Tennova Healthcare - Jamestown, and its associated assets are being acquired from Community Health Systems, Inc.(CYH). The transaction is expected to close in the second quarter of 2018, subject to customary regulatory approvals and closing conditions.
Tennova Healthcare - Jamestown is a fully operational 85-bed facility including a 24/7 emergency department, radiology department, surgical center, and a wound care & hyperbaric center. The purchase includes a 90,000 sq. ft. hospital building on approximately 8 acres.
"This acquisition further demonstrates our commitment to expanding Rennova's rural hospital model to provide necessary services to patients while securing more predictable recurring revenues," said Seamus Lagan, CEO of Rennova. "This hospital is approximately 38 miles (less than a one-hour drive) from our current hospital in Oneida and will benefit by receiving patients from Oneida that require operations and treatment not provided there. The synergy of management and services in a close geographic location creates numerous efficiencies for Rennova and will allow us to support a greater number of health care providers and residents in the local area."
About Rennova Health, Inc.(RNVA)
Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company's most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Contacts:
Rennova Health(RNVA)
Sebastien Sainsbury, 561-666-9818
ssainsbury@rennovahealth.com
Investors
LHA
Kim Golodetz, 212-838-3777
Kgolodetz@lhai.com
or
Bruce Voss, 310-691-7100
Bvoss@lhai.com
Source: Rennova Health, Inc.(RNVA)
RNVA News
Rennova Health Announces Definitive Agreement to Acquire Jamestown, Tennessee Hospital From Community Health Systems
MARKET WIRE 3:15 PM ET 01/31/2018
Symbol Last Price Change
RNVA 0.0165down -0.0035 (-17.5%)
CYH 5.65down -0.12 (-2.08%)
QUOTES AS OF 03:56:24 PM ET 01/31/2018
WEST PALM BEACH, FL -- (Marketwired) -- 01/31/18 -- Rennova Health, Inc.(RNVA), ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, that opened its first rural hospital in Oneida, Tenn. in August 2017, announced today that it has entered into a definitive asset purchase agreement to acquire an acute care hospital in Jamestown, Tenn. The hospital known as Tennova Healthcare - Jamestown, and its associated assets are being acquired from Community Health Systems, Inc.(CYH). The transaction is expected to close in the second quarter of 2018, subject to customary regulatory approvals and closing conditions.
Tennova Healthcare - Jamestown is a fully operational 85-bed facility including a 24/7 emergency department, radiology department, surgical center, and a wound care & hyperbaric center. The purchase includes a 90,000 sq. ft. hospital building on approximately 8 acres.
"This acquisition further demonstrates our commitment to expanding Rennova's rural hospital model to provide necessary services to patients while securing more predictable recurring revenues," said Seamus Lagan, CEO of Rennova. "This hospital is approximately 38 miles (less than a one-hour drive) from our current hospital in Oneida and will benefit by receiving patients from Oneida that require operations and treatment not provided there. The synergy of management and services in a close geographic location creates numerous efficiencies for Rennova and will allow us to support a greater number of health care providers and residents in the local area."
About Rennova Health, Inc.(RNVA)
Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company's most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Contacts:
Rennova Health(RNVA)
Sebastien Sainsbury, 561-666-9818
ssainsbury@rennovahealth.com
Investors
LHA
Kim Golodetz, 212-838-3777
Kgolodetz@lhai.com
or
Bruce Voss, 310-691-7100
Bvoss@lhai.com
Source: Rennova Health, Inc.(RNVA)
My timing seems perfect!!!!!
Nice. I was able to add all I wanted between .0165-.017. Breaking out my pom poms!!
I've picked up a few finally. Nothing this morning. I did an AON and got nothing!!!!!
I believe this has hit the bottom! I'm loading the boat.
Holy Moly!! I didn't get anything this morning.... damn!!! Congrates to all who did. BOOM!! Good call OBM!!
Nailed it!
Yes Etrade.
I guess its just an Eturd mistake.
Its on Eturd right now.
Either its a mistake on Etrade, or someone bought 60 million shares at.01. If the latter is true, being that we closed @ .0050, we gapped to .01 up 100% from yesterdays close. I'm hoping someone can confirm this either way. I certainly hope it isn't a mistake on Eturd.
Either way looks like we have a gapper this morning!
Last time I saw something like this was many years ago and it was a buyout. Not saying that this is happening here. But very strange.
Workspace
Snapshot
Positions (1)
Open Orders (1)
NUTRA PHARMA CORP COM NEW
?Refresh Quote
NPHC: NSDQ
Last Price
0.01
+0.0050 (+100.00%)
Bid (Size)
0.00 (x 0)
Ask (Size)
0.00 (x 0)
Volume
60.00M
TueWedThuFriMonTue-0.00500.0050.010.015
Day’s Range 0.00 ? 0.00
1d5d3m1y
Dividend Yield/Amount 0.00%/0.00
Ex-Dividend Date 0/0/0
Dividend Payable Date 5/18/2015
Last Refresh January 31, 2018 7:02 AM EST
Extended Hours
Real-Time Quotes
Seeing something quite strange on Eturd. Saying that the last trade was for 60m @.01 100% gain........hmmmm
Agreed! That's certainly is a rarity. "The not so stinky, pinky"
Good morning everyone. I'm going to be on the bid this morning. Being this early in the game, I can see us getting some decent dips. Id like to get a base set up before Tuesday.
If it drops below .02 I'm back in this morning.
I have a couple more days in NPHC. That's been nice to me as well. Been working it for well over a week.
Oh am I interested, I like money. Joe and VUME have made me a mint! Still holding almost 200k of freebies there, when the board is reported and the ticker change is out...Those remaining freebies will be awesome.
Very nice find. He has been making people very happy as of late.
Well we had a 911 trade at the end of day. If you believe those sort of things, means NEWS pending tomorrow.
I didn't get to add anymore then my freebies. Lets see what today holds for us.
Bingo! We now have our new President and board member. 1st big step, we should hear the full board this week. I'm really hoping for a symbol change to BUDS. I checked it, its available!!